EZH2 and Miyoshi myopathy: Remarkably, EZH2 inhibition did not improve the ADCC lysis mediated by anti-CD38 MoAb in CD38high MM cells (Supplementary Fig. S4D) supporting the hypothesis that ADCC improvement is significantly mediated, at least in part, by CD38 upregulation.